Quantedge Capital Pte Ltd lessened its stake in shares of BlackRock Health Sciences Term Trust (NYSE:BMEZ – Free Report) by 42.8% during the fourth quarter, Holdings Channel.com reports. The institutional investor owned 88,854 shares of the company’s stock after selling 66,511 shares during the period. Quantedge Capital Pte Ltd’s holdings in BlackRock Health Sciences Term Trust were worth $1,279,000 at the end of the most recent reporting period.
A number of other large investors have also recently bought and sold shares of the stock. Estabrook Capital Management purchased a new position in shares of BlackRock Health Sciences Term Trust during the 4th quarter worth $35,000. Yakira Capital Management Inc. purchased a new position in shares of BlackRock Health Sciences Term Trust during the 4th quarter worth $153,000. Virtu Financial LLC purchased a new position in shares of BlackRock Health Sciences Term Trust during the 4th quarter worth $206,000. K2 Principal Fund L.P. lifted its stake in shares of BlackRock Health Sciences Term Trust by 62.7% during the 4th quarter. K2 Principal Fund L.P. now owns 16,271 shares of the company’s stock worth $234,000 after purchasing an additional 6,271 shares during the period. Finally, Cary Street Partners Financial LLC purchased a new position in shares of BlackRock Health Sciences Term Trust during the 4th quarter worth $236,000.
BlackRock Health Sciences Term Trust Stock Up 0.7%
Shares of BMEZ opened at $14.52 on Thursday. The stock’s fifty day simple moving average is $14.41 and its 200 day simple moving average is $15.18. BlackRock Health Sciences Term Trust has a twelve month low of $12.58 and a twelve month high of $16.75.
BlackRock Health Sciences Term Trust Cuts Dividend
BlackRock Health Sciences Term Trust Company Profile
BlackRock Health Sciences Trust II’s (BMEZ) (the ‘Trust’) investment objective is to provide total return and income through a combination of current income, current gains and long-term capital appreciation. The Trust seeks to achieve its investment objective by investing, under normal market conditions, at least 80% of its total assets in equity securities of companies principally engaged in the health sciences group of industries and equity derivatives with exposure to the health sciences group of industries.
Recommended Stories
- Five stocks we like better than BlackRock Health Sciences Term Trust
- What is the S&P 500 and How It is Distinct from Other Indexes
- SMCI Stock Rally: 45% Gain in 2 Days Could Be Just the Start
- How to Invest in Biotech Stocks
- AMD’s AI-Powered Stock Price Rally Just Shifted Gears
- What Are Earnings Reports?
- 5 Hot Small-Cap Insiders Bought at the Peak of Tariff Fears
Want to see what other hedge funds are holding BMEZ? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for BlackRock Health Sciences Term Trust (NYSE:BMEZ – Free Report).
Receive News & Ratings for BlackRock Health Sciences Term Trust Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for BlackRock Health Sciences Term Trust and related companies with MarketBeat.com's FREE daily email newsletter.